Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $1.147B (100.0% shares, 0.0% debt)

Holdings (33)

BMRN BIOMARIN PHARMACEUTICAL INC 14.9%
Value $171M Shares 2,061,373 Est. Cost $83.16 Unrealized -4.3%
UTHR UNITED THERAPEUTICS CORP 13.0%
Value $150M Shares 634,806 Est. Cost $89.23 Unrealized +127.8%
ABIOMED INC 10.7%
Value $122M Shares 494,397 Est. Cost $81.43 Unrealized
INSM INSMED INC 10.0%
Value $115M Shares 5,840,398 Est. Cost $17.79 Unrealized +17.8%
FOLD AMICUS THERAPEUTICS INC 9.2%
Value $106M Shares 9,847,774 Est. Cost $9.52 Unrealized -13.5%
STAA STAAR SURGICAL CO 6.8%
Value $78.49M Shares 1,106,567 Est. Cost $14.28 Unrealized +351.3%
BIIB BIOGEN INC 6.4%
Value $73.62M Shares 360,981 Est. Cost $264.06 Unrealized -22.6%
REVANCE THERAPEUTICS INC 5.3%
Value $60.88M Shares 4,405,039 Est. Cost $21.99 Unrealized
PRTA PROTHENA CORP PLC 4.0%
Value $45.65M Shares 1,681,477 Est. Cost $21.46 Unrealized +36.3%
SAGE THERAPEUTICS INC 2.4%
Value $27.5M Shares 851,409 Est. Cost $46.62 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.4%
Value $27.15M Shares 2,491,200 Est. Cost $11.21 Unrealized -7.6%
KARYOPHARM THERAPEUTICS INC 2.2%
Value $25.35M Shares 5,621,533 Est. Cost $16.36 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.1%
Value $23.65M Shares 1,678,196 Est. Cost $33.89 Unrealized -44.9%
ALKS ALKERMES PLC 1.6%
Value $17.98M Shares 603,400 Est. Cost $22.36 Unrealized +28.5%
EHTH EHEALTH INC 1.3%
Value $15.44M Shares 1,654,693 Est. Cost $59.40 Unrealized -82.9%
GOSS GOSSAMER BIO INC 1.3%
Value $14.65M Shares 1,750,651 Est. Cost $11.85 Unrealized -34.6%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value $11.79M Shares 612,600 Est. Cost $16.84 Unrealized -1.1%
ALGN ALIGN TECHNOLOGY INC 0.9%
Value $10.49M Shares 44,305 Est. Cost $114.31 Unrealized +168.8%
EPIZYME INC 0.9%
Value $9.959M Shares 6,774,541 Est. Cost $11.87 Unrealized
ANAB ANAPTYSBIO INC 0.8%
Value $8.75M Shares 431,024 Est. Cost $19.06 Unrealized +16.2%
CLOVIS ONCOLOGY INC 0.7%
Value $8.053M Shares 4,473,967 Est. Cost $42.71 Unrealized
GRITSTONE ONCOLOGY INC 0.5%
Value $5.64M Shares 2,330,504 Est. Cost $9.42 Unrealized
KEZAR LIFE SCIENCES INC 0.5%
Value $5.427M Shares 656,200 Est. Cost $5.16 Unrealized
CYTK CYTOKINETICS INC 0.4%
Value $4.389M Shares 111,717 Est. Cost $6.71 Unrealized +499.7%
TVTX TRAVERE THERAPEUTICS INC 0.4%
Value $4.024M Shares 166,069 Est. Cost $23.56 Unrealized +6.8%
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.259M Shares 64,700 Est. Cost $15.56 Unrealized +51.6%
ALIMERA SCIENCES INC 0.1%
Value $1.099M Shares 200,919 Est. Cost $6.30 Unrealized
NVAX NOVAVAX INC 0.1%
Value $643K Shares 12,500 Est. Cost $171.82 Unrealized -69.9%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $642K Shares 160,800 Est. Cost $7.10 Unrealized -51.5%
MAGENTA THERAPEUTICS INC 0.0%
Value $519K Shares 432,300 Est. Cost $7.38 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value $201K Shares 24,500 Est. Cost $27.01 Unrealized -74.6%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $198K Shares 27,100 Est. Cost $39.74 Unrealized -68.1%
MARINUS PHARMACEUTICALS INC 0.0%
Value $152K Shares 31,330 Est. Cost $15.48 Unrealized